Glaucoma Therapeutics Market Report by Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Others), and Region 2024-2032

Glaucoma Therapeutics Market Report by Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A2770
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Glaucoma Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Prostaglandin Analogs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Beta Blockers
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Alpha Adrenergic Agonists
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Carbonic Anhydrase Inhibitors
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Combination Drugs
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Indication
    7.1    Open Angle Glaucoma
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Angle Closure Glaucoma
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ophthalmic Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Ambulatory Surgery Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Aerie Pharmaceuticals Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Allergan Plc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 SWOT Analysis
        14.3.4    Inotek Pharmaceuticals Corp.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Merck & Co. Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Novartis AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Pfizer Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Santen Pharmaceutical Co. Ltd.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    SIFI S.p.A
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    Teva Pharmaceutical Industries Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Glaucoma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Glaucoma Therapeutics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Glaucoma Therapeutics Market: Breakup by Drug Class (in %), 2023
Figure 4: Global: Glaucoma Therapeutics Market: Breakup by Indication (in %), 2023
Figure 5: Global: Glaucoma Therapeutics Market: Breakup by End User (in %), 2023
Figure 6: Global: Glaucoma Therapeutics Market: Breakup by Region (in %), 2023
Figure 7: Global: Glaucoma Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Glaucoma Therapeutics (Prostaglandin Analogs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Glaucoma Therapeutics (Prostaglandin Analogs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Glaucoma Therapeutics (Beta Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Glaucoma Therapeutics (Beta Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Glaucoma Therapeutics (Alpha Adrenergic Agonists) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Glaucoma Therapeutics (Alpha Adrenergic Agonists) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Glaucoma Therapeutics (Carbonic Anhydrase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Glaucoma Therapeutics (Carbonic Anhydrase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Glaucoma Therapeutics (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Glaucoma Therapeutics (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Glaucoma Therapeutics (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Glaucoma Therapeutics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Glaucoma Therapeutics (Open Angle Glaucoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Glaucoma Therapeutics (Open Angle Glaucoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Glaucoma Therapeutics (Angle Closure Glaucoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Glaucoma Therapeutics (Angle Closure Glaucoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Glaucoma Therapeutics (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Glaucoma Therapeutics (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Glaucoma Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Glaucoma Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Glaucoma Therapeutics (Ophthalmic Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Glaucoma Therapeutics (Ophthalmic Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Glaucoma Therapeutics (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Glaucoma Therapeutics (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Glaucoma Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Glaucoma Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia Pacific: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia Pacific: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Glaucoma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Glaucoma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Glaucoma Therapeutics Industry: SWOT Analysis
Figure 83: Global: Glaucoma Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Glaucoma Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Glaucoma Therapeutics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Glaucoma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Glaucoma Therapeutics Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Glaucoma Therapeutics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Glaucoma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Glaucoma Therapeutics Market: Competitive Structure
Table 7: Global: Glaucoma Therapeutics Market: Key Players

Glaucoma Therapeutics Market Report by Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More